There are 2934 resources available
Liquid biopsies to predict response or resistance in IO
Presenter: Dominic Rothwell
Session: Which are the preferred platforms for IO biomarkers discovery?
Resources:
Slides
Webcast
Conclusions and perspectives
Presenter: John Haanen
Session: Which are the preferred platforms for IO biomarkers discovery?
Resources:
Slides
Webcast
Introduction
Presenter: Alberto Sobrero
Session: Adjuvant treatment duration for high-risk stage II colon cancer
Resources:
Slides
Webcast
How do you treat high-risk stage II colon cancer patients? Nothing vs. FP vs. doublet including MSI high patients
Presenter: Claus-Henning Koehne
Session: Adjuvant treatment duration for high-risk stage II colon cancer
Resources:
Slides
Webcast
IDEA collaboration for HR stage II
Presenter: Alberto Sobrero
Session: Adjuvant treatment duration for high-risk stage II colon cancer
Resources:
Slides
Webcast
SCOT trial
Presenter: Timothy Iveson
Session: Adjuvant treatment duration for high-risk stage II colon cancer
Resources:
Slides
Webcast
TOSCA trial
Presenter: Sara Lonardi
Session: Adjuvant treatment duration for high-risk stage II colon cancer
Resources:
Slides
Webcast
HORG trial
Presenter: Ioannis Souglakos
Session: Adjuvant treatment duration for high-risk stage II colon cancer
Resources:
Slides
Webcast
Panel discussion
Presenter: Claus-Henning Koehne
Session: Adjuvant treatment duration for high-risk stage II colon cancer
Resources:
Slides
Webcast
New IDEA collaboration ‘CIRCULATE IDEA’
Presenter: Takayuki Yoshino
Session: Adjuvant treatment duration for high-risk stage II colon cancer
Resources:
Slides
Webcast